Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-024898
Filing Date
2013-04-30
Accepted
2013-04-30 10:44:51
Documents
1
Period of Report
2013-04-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v343237_4.html 4  
1 OWNERSHIP DOCUMENT v343237_4.xml 4 3101
  Complete submission text file 0001144204-13-024898.txt   4720
Mailing Address 675 ALMANOR AVE. SUNNYVALE CA 94085
Business Address 675 ALMANOR AVE. SUNNYVALE CA 94085 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Issuer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 ALMANOR AVENUE SUNNYVALE CA 94085
Business Address
COMMISSIONG GERALD (Reporting) CIK: 0001566928 (see all company filings)

Type: 4 | Act: 34 | File No.: 333-148922 | Film No.: 13795142